Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by F. Bonino
Budget Impact of an Individualized Approach in the Treatment of HBeAg-Negative CHB Patients Exploiting the Week-12 Peginterferon Alfa-2a Stopping Rule in Italy
Value in Health
Medicine
Health Policy
Public Health
Occupational Health
Environmental
Transmission of the Hepatitis B Virus-Associated Delta Agent to the Eastern Woodchuck.
Proceedings of the National Academy of Sciences of the United States of America
Multidisciplinary
Related publications
Serum Hepatitis B Virus RNA Levels as a Predictor of HBeAg Seroconversion During Treatment With Peginterferon Alfa-2a
Virology Journal
Virology
Infectious Diseases
PGI18 Treatment of Chronic Hepatitis C Patients With Peginterferon Alfa-2a or Peginterferon Alfa-2b: A Cost-Effectiveness Analysis for the Portuguese NHS Setting
Value in Health
Medicine
Health Policy
Public Health
Occupational Health
Environmental
Cost-Effectiveness Analysis of Treatment With Peginterferon-Alfa-2a Versus Peginterferon-Alfa-2b for Patients With Chronic Hepatitis C Under the Public Payer Perspective in Brazil
Cost Effectiveness and Resource Allocation
Health Policy
Editorial: A Baseline Tool for Predicting Response to Peginterferon Alfa-2a in HBeAg-positive Patients-Same Score, Different Outcomes
Alimentary Pharmacology and Therapeutics
Hepatology
Pharmacology
Gastroenterology
Peginterferon Alfa-2a in Patients With Chronic Hepatitis C and Cirrhosis
New England Journal of Medicine
Medicine
The Change of Quantitative of HBeAg Can Predict the Efficacy of Peg-Ifn-Α 2a in HBeAgpositive CHB Patients
Infection International
Virological Response to Treatment With Peginterferon Alfa-2a in Adolescents With Chronic Hepatitis B.
Acta Biochimica Polonica
Biochemistry
Genetics
Molecular Biology
Peginterferon Alfa-2a Is Associated With Elevations in Alanine Aminotransferase at the End of Treatment in Chronic Hepatitis C Patients With Sustained Virologic Response
PLoS ONE
Multidisciplinary
Relapse Rate and Associated-Factor of Recurrence After Stopping NUCs Therapy With Different Prolonged Consolidation Therapy in HBeAg Positive CHB Patients
PLoS ONE
Multidisciplinary
